PROSERA Study Overview and Baseline Characteristics ...

Despite a decided shortage of placebo-controlled trials in humans to support that advice, the business of longevity is ...

The microbes that live in our mouth and gut may influence whether an allergic reaction to peanuts is mild or life-threatening, and could be harnessed to ward off a severe attack ...

Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...

Ascendis Pharma is spiraling upward by way of its TransCon platform. | Ascendis Pharma is spiraling upward by way of its TransCon platform. For the third time in six years, the Copenhagen-based ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Aligned with FDA on dual-trial design Phase 3 program that aims to demonstrate robust efficacy and long-term safety and that allows for flexible ...

Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...

Waldorf schools tend to attract parents who don’t want their kids to eat junk food or play Fortnite; they also draw a fair number who skip vaccines. During the pandemic, I began to hear considerable ...

Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, rezpegaldesleukin (rezpeg), in atopic dermatitis (AD).

Many readers are incensed that federal health officials may go after vaccines containing minuscule amounts of aluminum salts.

A nurse scientist interviewed 29 formerly incarcerated Black men in Philadelphia to understand how they address their mental health needs.